| Therapy Area Communications & Patient Advocacy Lead |
Barcelona Gran Vía |
Spain |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 14, 2025 |
| Manager, US Reputation & Corporate Storytelling |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 10, 2025 |
| Communication & Patient Advocacy Manager Greece |
Metamorfosis |
Greece |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 09, 2025 |
| Vice President of European Public Affairs |
Brussels |
Belgium |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Ιαν 08, 2025 |
| Communications & Patient Advocacy Manager |
Selangor |
Malaysia |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Ιαν 07, 2025 |
| Associate Director, R&D Executive Communications and Storytelling |
Cambridge (USA) |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 03, 2025 |
| Director of Communications and Media Engagement for Finance and Strategy & Growth organizations |
Basel (City) |
Switzerland |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Δεκ 16, 2024 |
| Executive Director, Public Affairs WEC |
Basel (City) |
Switzerland |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Δεκ 16, 2024 |
| Executive Director, Public Affairs (SERCE Czech Republic, Hungary, Poland, Russia, ECC) |
Basel (City) |
Switzerland |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Δεκ 16, 2024 |
| Head of Public Affairs, Ireland |
Dublin (Country President Office (CPO)) |
Ireland |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Δεκ 12, 2024 |
| Director, Emerging Policies Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
Switzerland |
People & Organization |
Corporate |
Communications & Public Affairs |
Δεκ 10, 2024 |
| Country Head, Comms & Patient Advocacy |
Amsterdam |
Netherlands |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Δεκ 09, 2024 |
| Senior Manager, Owned Channel Strategy and Intelligence |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Δεκ 04, 2024 |
| Associate Director, Patient Engagement, Neuroscience and Gene Therapies |
East Hanover |
USA |
Development |
Innovative Medicines |
Communications & Public Affairs |
Δεκ 03, 2024 |
| Therapy Area Communications & Patient Advocacy Manager |
Barcelona Gran Vía |
Spain |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Δεκ 03, 2024 |
| Senior Manager Portfolio Advocacy, Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
Switzerland |
People & Organization |
Corporate |
Communications & Public Affairs |
Δεκ 02, 2024 |
| Senior Manager Policy, Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
Switzerland |
People & Organization |
Corporate |
Communications & Public Affairs |
Δεκ 02, 2024 |
| Head, Portfolio Policy |
East Hanover |
USA |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Δεκ 02, 2024 |
| Lead - Government Affairs |
Delhi (Office) |
India |
International |
Innovative Medicines |
Communications & Public Affairs |
Νοε 26, 2024 |
| Public Affairs Manager |
Ankara Gimat |
Türkiye |
International |
Innovative Medicines |
Communications & Public Affairs |
Σεπ 13, 2024 |
| Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Communications & Public Affairs |
Ιουλ 09, 2024 |